Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Lymphoid 1Head & Neck 1

Conditions

Head and Neck Neoplasms 14Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 6Tongue Neoplasms 4Salivary Gland Neoplasms 3Carcinoma, Squamous Cell 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Carcinoma, Medullary 2Adenocarcinoma, Follicular 2Xerostomia 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Neoplasms, Squamous Cell 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma 1Locally Advanced Thyroid Gland Carcinoma 1Hereditary Sensory and Autonomic Neuropathies 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1

Interventions

Fulvestrant 2Alpelisib 2tipifarnib 1ribociclib 1palbociclib 1exemestane 1abemaciclib 1Tamoxifen 1STX-478 1SF 1126 1Panobinostat 1PX-866 1Metformin 1Letrozole 1Imlunestrant 1Everolimus 1Docetaxel 1Cetuximab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Everolimus × Head & Neck × Clear all
NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

National Cancer Centre, Singapore

Phase 1 Unknown
49 enrolled
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡